Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SLFN11 contributors: mct/npt - updated : 21-12-2016
HGNC name schlafen family member 11
HGNC id 26633
DNA
TYPE functioning gene
SPECIAL FEATURE component of a cluster
STRUCTURE 23.40 kb     7 Exon(s)
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
5 - 5015 - 901 - 2009 19592487
variant 5
7 - 5122 - 901 - 2009 19592487
variant 4
6 - 5132 - 901 - 2009 19592487
variant 3
7 - 5210 - 901 - 2009 19592487
variant 2
7 - 5292 - 901 - 2009 19592487
variant 1
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
cells
SystemCellPubmedSpeciesStageRna symbol
Blood/Hematopoieticmonocyte Homo sapiens
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • common N-terminal (AAA) domain that is involved in GTP/ATP binding (Katsoulidis 2009)
  • HOMOLOGY
    Homologene
    FAMILY
  • schlafen family
  • CATEGORY immunity/defense
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • control cell cycle progression and growth arrest (Katsoulidis 2009)
  • promote growth inhibitory responses and modulate cell cycle progression by inhibiting cyclin D1 (Katsoulidis 2009)
  • SLFN11 expression is causally associated with the activity of DNA-damaging agents (DDAs) in cancer cells
  • is likely a component of the DNA damage response, enforcing cell cycle arrest and apoptosis in response to exogenous DNA injuries
  • inhibits checkpoint maintenance and homologous recombination repair by promoting the destabilization of the RPA-ssDNA complex, thereby sensitizing cancer cell lines expressing high endogenous levels of SLFN11 to DNA-damaging agents
  • RPA1-binding ability of SLFN11 is required for its function in the DNA damage response
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • ETS1 acts as a positive regulator for SLFN11 expression in breast cancer cells
  • SLFN11 interacts directly with RPA1 and is recruited to sites of DNA damage in an RPA1-dependent manner
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    correlate with the sensitivity of human cancer cells to DNA-damaging agent
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • SLFN11 expression can serve as a biomarker to predict responses to DNA-damaging therapeutic agents
  • Therapy target
    ANIMAL & CELL MODELS